17 completed, 2 terminated, 2 unknown, 1 recruiting. 22 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 17, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow prucalopride: new trials by email Literature Review of prucalopride trials Research Report on prucalopride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Varying Doses of Prucalopride on Improving Gut Function Recovery After Elective Colorectal Surgery Prucalopride 2mg, Prucalopride 4mg, Standard Care - Post-Op Complication | Phase 3 | Recruiting | Future University in Egypt | 180 | 2025-03-02 | 2025-03-19 |
| Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure polyethylene glycol, sodium phosphate, polyethylene glycol + ascorbic acid - Colon Cancer, Inflammatory Bowel Diseases | Phase 3 | Completed | Region Skane | 147 | 2023-02-01 | 2024-02-28 |
| A Study of Prucalopride For Functional Constipation in Children and Teenagers Prucalopride, Placebo - Constipation | Phase 3 | Terminated | Takeda | 175 | 2021-07-13 | 2024-06-06 |
| The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome Prucalopride 2mg - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 160 | 2021-03-10 | 2021-10-22 |
| Prucalopride in Postoperative Ileus Prucalopride, Placebo Oral Capsule - Postoperative Ileus, Colorectal Surgery | Phase 3 | Completed | University of Auckland, New Zealand | 150 | 2017-10-25 | 2021-09-29 |
| Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus Prucalopride, Placebo - Paralytic Ileus, Critically Ill | Phase 3 | Unknown | Prince of Songkla University | 62 | 2017-07-01 | 2020-02-06 |
| Prucalopride Versus Placebo in Gastroparesis Prucalopride, Placebo - Gastroparesis, Diabetes Mellitus | Phase 2 / Phase 3 | Completed | University of Calgary | 15 | 2014-03-01 | 2020-10-08 |
| Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule Prucalopride, Colon Capsule - Bowel Cleansing, Colon Capsule Completion Times | Phase 3 | Completed | Queen's University | 60 | 2013-06-01 | 2017-02-16 |
| Improving Bowel Preparation for the Colon Capsule PEG, Prucalopride, Picosalax - Quality of Bowel Preparation for the Colon Capsule, Colon Capsule Completion Rates | Phase 3 | Completed | Queen's University | 20 | 2012-07-01 | 2015-12-03 |
| Prucalopride in Pediatric Subjects With Functional Constipation prucalopride, Placebo, PEG 4000 - Functional Constipation | Phase 3 | Completed | Shire | 215 | 2011-04-28 | 2021-06-10 |
| Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation PEG 3350 plus electrolytes, Prucalopride - Constipation | Phase 3 | Completed | Norgine | 240 | 2010-11-01 | 2012-08-31 |
| Evaluation of Prucalopride in Male Subjects With Chronic Constipation. Placebo, Prucalopride - Male Subjects With Chronic Constipation | Phase 3 | Completed | Shire | 374 | 2010-09-23 | 2021-06-10 |
| Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation placebo, prucalopride - Non-cancer Pain, Opioid Induced Constipation | Phase 3 | Terminated | Shire | 174 | 2010-05-19 | 2021-06-11 |
| An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation Prucalopride, Placebo - Constipation | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 507 | 2010-05-01 | 2017-03-21 |
| Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation Prucalopride, Placebo - Constipation | Phase 3 | Completed | Movetis | 516 | 1999-04-01 | 2008-05-29 |
| Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation prucalopride, Prucalopride, Placebo - Constipation | Phase 3 | Completed | Movetis | 303 | 1998-10-01 | 2008-05-29 |
| Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation Prucalopride, Placebo - Constipation | Phase 3 | Completed | Movetis | 755 | 1998-08-01 | 2008-05-29 |
| Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation Prucalopride - Chronic Constipation | Phase 3 | Completed | Movetis | 1775 | 1998-07-01 | 2009-10-01 |
| Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation Prucalopride - Chronic Constipation | Phase 3 | Completed | Movetis | 693 | 1998-06-01 | 2010-03-02 |
| Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation Prucalopride, Placebo - Constipation | Phase 3 | Completed | Movetis | 620 | 1998-04-01 | 2013-04-11 |
Showing 20 of 22. Sign in to see all of them.
Constipation (10) · Postoperative Complications (2) · Colonic Neoplasms (1) · Colonic Polyps (1) · Critical Illness (1) · Diabetes Mellitus (1) · Gastrointestinal Hemorrhage (1) · Gastroparesis (1) · Inflammatory Bowel Diseases (1) · Intestinal Pseudo-Obstruction (1) · Irritable Bowel Syndrome (1) · Opioid-Induced Constipation (1)
Movetis (8) · Shire (3) · Queen's University (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Future University in Egypt (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Norgine (1) · Prince of Songkla University (1) · Region Skane (1) · Takeda (1) · University of Auckland, New Zealand (1) · University of Calgary (1)
Belgium (3) · Canada (3) · Netherlands (2) · Romania (2) · Thailand (2) · United States (2) · Australia (1) · Bangladesh (1) · Bulgaria (1) · China (1) · Czechia (1) · Denmark (1) · Egypt (1) · France (1) · Germany (1)
Lawrence Hookey (2) · Christopher N Andrews, MD, MSc (1) · Darlene Brady (1) · Ervin Toth, MD PhD (1) · Gerald Demschik, M.D. (1) · Ghislain Devroede, M.D. (1) · John F Johanson, M.D. (1) · John F Johanson, MD, MSc (1) · Marc Van Outryve, MD (1) · Michael Camilleri, M.D. (1) · Michael Camilleri, MD (1)
PMID 34585675, PMID 39664231, PMID 24106924, PMID 24917940, PMID 25581251, PMID 21039673, PMID 18509121, PMID 18987031, PMID 20529205, PMID 23480216, PMID 25239590, PMID 25869393, PMID 27891230, PMID 35639621, PMID 37215389
2009 (2)